0000-0002-8521-0108 Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study Save
- Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects Save
- Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound Save
- Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660) Save
- Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-piperaquine or Artemether-lumefantrine in Healthy Adult Subjects Save
- Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor Save
- A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response Save
- The Role of Drug Exposure in Clinical Development: To What Extent Is Pharmacokinetic Assessment Needed in a Drug Development Programme? Save
- Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria Save
- Safety and pharmacology of a soluble epoxide hydrolase inhibitor Save